Erydel   Report issue

For profit Phase 3
Founded: San Giovanni Italy (2007)

Organization Overview

First Clinical Trial
2009
NCT01277289
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Erydel | EryDel S.p.A